Drug Discovery & Development | InterMune Announces Additional Pirfenidone Data in Idiopathic Pulmonary ... MarketWatch Ltd. Under different trade names, pirfenidone is also approved for the treatment of IPF in China, India, Argentina and Mexico. Pirfenidone is not approved for sale in the United States. About IPF Idiopathic pulmonary fibrosis (IPF) is an irreversible ... InterMune Up on Esbriet Data Presentation - Analyst Blog Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis ... |
